{"id":697,"date":"2024-02-29T09:58:00","date_gmt":"2024-02-29T08:58:00","guid":{"rendered":"https:\/\/temporary.nolato.com\/mfn_news\/nolato-redovisar-jamforelsetal-for-den-nya-koncernstrukturen\/"},"modified":"2024-02-29T09:58:00","modified_gmt":"2024-02-29T08:58:00","slug":"nolato-redovisar-jamforelsetal-for-den-nya-koncernstrukturen","status":"publish","type":"mfn_news","link":"https:\/\/temporary.nolato.com\/fr\/mfn_news\/nolato-redovisar-jamforelsetal-for-den-nya-koncernstrukturen\/","title":{"rendered":"Nolato redovisar j\u00e4mf\u00f6relsetal f\u00f6r den nya koncernstrukturen"},"content":{"rendered":"
\n

Som tidigare kommunicerats driver Nolato, fr\u00e5n och med det f\u00f6rsta kvartalet 2024, koncernens verksamhet i tv\u00e5 aff\u00e4rsomr\u00e5den \u2013 Medical Solutions och Engineered Solutions. I det nya aff\u00e4rsomr\u00e5det Engineered Solutions ing\u00e5r de tidigare omr\u00e5dena Industrial, Konsumentelektronik samt EMC.<\/p>\n

Nedan visas kvartals- och hel\u00e5rssiffror avseende 2022 samt 2023 enligt den nya koncernstrukturen. Rapporten f\u00f6r f\u00f6rsta kvartalet 2024 kommer att publiceras den 6 maj.<\/p>\n

Oms\u00e4ttning och marginal per segment<\/strong><\/p>\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n
Nettooms\u00e4ttning<\/strong> (MSEK)<\/td>\n<\/td>\nQ1<\/strong><\/td>\nQ2<\/strong><\/td>\nQ3<\/strong><\/td>\nQ4<\/strong><\/td>\nHel\u00e5r<\/strong><\/td>\n<\/tr>\n
<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/tr>\n
Medical Solutions<\/td>\n2023<\/td>\n1 324<\/td>\n1 364<\/td>\n1 320<\/td>\n1 300<\/td>\n5 308<\/td>\n<\/tr>\n
<\/td>\n2022<\/td>\n1 088<\/td>\n1 214<\/td>\n1 245<\/td>\n1 312<\/td>\n4 859<\/td>\n<\/tr>\n
<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/tr>\n
Engineered Solutions<\/td>\n2023<\/td>\n1 153<\/td>\n1 114<\/td>\n1 020<\/td>\n958<\/td>\n4 245<\/td>\n<\/tr>\n
<\/td>\n2022<\/td>\n1 792<\/td>\n1 693<\/td>\n1 382<\/td>\n1 055<\/td>\n5 922<\/td>\n<\/tr>\n
<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/tr>\n
Koncernjusteringar, moderbolag<\/td>\n2023<\/td>\n-1<\/td>\n\u2013<\/td>\n\u2013<\/td>\n-6<\/td>\n-7<\/td>\n<\/tr>\n
<\/td>\n2022<\/td>\n-1<\/td>\n-2<\/td>\n-1<\/td>\n-3<\/td>\n-7<\/td>\n<\/tr>\n
<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/tr>\n
Totalt koncernen<\/td>\n2023<\/td>\n2 476<\/td>\n2 478<\/td>\n2 340<\/td>\n2 252<\/td>\n9 546<\/td>\n<\/tr>\n
<\/td>\n2022<\/td>\n2 879<\/td>\n2 905<\/td>\n2 626<\/td>\n2 364<\/td>\n10 774<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n

<\/p>\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n
R\u00f6relseresultat<\/strong> (EBITA) (MSEK)<\/td>\n<\/td>\nQ1<\/strong><\/td>\nQ2<\/strong><\/td>\nQ3<\/strong><\/td>\nQ4<\/strong><\/td>\nHel\u00e5r<\/strong><\/td>\n<\/tr>\n
<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/tr>\n
Medical Solutions<\/td>\n2023<\/td>\n132<\/td>\n138<\/td>\n126<\/td>\n129<\/td>\n525<\/td>\n<\/tr>\n
EBITA-marginal, %<\/em><\/td>\n<\/td>\n10,0<\/em><\/td>\n10,1<\/em><\/td>\n9,5<\/em><\/td>\n9,9<\/em><\/td>\n9,9<\/em><\/td>\n<\/tr>\n
<\/td>\n2022<\/td>\n106<\/td>\n121<\/td>\n104<\/td>\n126<\/td>\n457<\/td>\n<\/tr>\n
EBITA-marginal, %<\/em><\/td>\n<\/td>\n9,7<\/em><\/td>\n10,0<\/em><\/td>\n8,4<\/em><\/td>\n9,6<\/em><\/td>\n9,4<\/em><\/td>\n<\/tr>\n
<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/tr>\n
Engineered Solutions<\/td>\n2023<\/td>\n68<\/td>\n72<\/td>\n74<\/td>\n52<\/td>\n266<\/td>\n<\/tr>\n
EBITA-marginal, %<\/em><\/td>\n<\/td>\n5,9<\/em><\/td>\n6,5<\/em><\/td>\n7,3<\/em><\/td>\n5,4<\/em><\/td>\n6,3<\/em><\/td>\n<\/tr>\n
<\/td>\n2022<\/td>\n163<\/td>\n146<\/td>\n110<\/td>\n43<\/td>\n462<\/td>\n<\/tr>\n
EBITA-marginal, %<\/em><\/td>\n<\/td>\n9,1<\/em><\/td>\n8,6<\/em><\/td>\n8,0<\/em><\/td>\n4,1<\/em><\/td>\n7,8<\/em><\/td>\n<\/tr>\n
<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/tr>\n
Koncernjusteringar, moderbolag<\/td>\n2023<\/td>\n-7<\/td>\n-12<\/td>\n-67<\/td>\n-4<\/td>\n-90<\/td>\n<\/tr>\n
<\/td>\n2022<\/td>\n-2<\/td>\n-3<\/td>\n\u2013<\/td>\n-6<\/td>\n-11<\/td>\n<\/tr>\n
<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/tr>\n
Totalt koncernen<\/td>\n2023<\/td>\n193<\/td>\n198<\/td>\n133<\/td>\n177<\/td>\n701<\/td>\n<\/tr>\n
EBITA-marginal, %<\/em><\/td>\n<\/td>\n7,8<\/em><\/td>\n8,0<\/em><\/td>\n5,7<\/em><\/td>\n7,9<\/em><\/td>\n7,3<\/em><\/td>\n<\/tr>\n
<\/td>\n2022<\/td>\n267<\/td>\n264<\/td>\n214<\/td>\n163<\/td>\n908<\/td>\n<\/tr>\n
EBITA-marginal, %<\/em><\/td>\n<\/td>\n9,3<\/em><\/td>\n9,1<\/em><\/td>\n8,1<\/em><\/td>\n6,9<\/em><\/td>\n8,4<\/em><\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<\/div>\n
\n

Kontakt<\/strong><\/p>\n

\n

Per-Ola Holmstr\u00f6m, finansdirekt\u00f6r, 0705 763340, per-ola.holmstrom@nolato.com<\/a><\/p>\n<\/div>\n

\n

Om oss<\/strong><\/p>\n

\n

Nolato \u00e4r en svensk koncern med verksamhet i Europa, Asien och Nordamerika. Vi utvecklar och tillverkar produkter i polymera material som plast, silikon och TPE till ledande kunder inom medicinteknik, l\u00e4kemedel, konsumentelektronik, telekom, fordon, hygien och andra utvalda industriella sektorer. Nolatoaktien noteras p\u00e5 Nasdaq Stockholm, d\u00e4r Nolato \u00e4r ett Large Cap-f\u00f6retag i sektorn Industrials. \u00a0<\/em>www.nolato.se\/IR<\/a><\/em><\/p>\n<\/div>\n

\n

Bifogade filer<\/strong><\/p>\n

\n

Nolato redovisar j\u00e4mf\u00f6relsetal f\u00f6r den nya koncernstrukturen<\/a><\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"

Som tidigare kommunicerats driver Nolato, fr\u00e5n och med det f\u00f6rsta kvartalet 2024, koncernens verksamhet i tv\u00e5 aff\u00e4rsomr\u00e5den \u2013 Medical Solutions och Engineered Solutions. I det nya aff\u00e4rsomr\u00e5det Engineered Solutions ing\u00e5r de tidigare omr\u00e5dena Industrial, Konsumentelektronik samt EMC. Nedan visas kvartals- och hel\u00e5rssiffror avseende 2022 samt 2023 enligt den nya koncernstrukturen. Rapporten f\u00f6r f\u00f6rsta kvartalet 2024… Continue reading Nolato redovisar j\u00e4mf\u00f6relsetal f\u00f6r den nya koncernstrukturen<\/span><\/a><\/p>\n","protected":false},"template":"","class_list":["post-697","mfn_news","type-mfn_news","status-publish","hentry","mfn-news-tag-mfn-ci","mfn-news-tag-mfn-type-ir","mfn-news-tag-mfn","mfn-news-tag-mfn-ci-other","mfn-news-tag-mfn-lang-sv","entry"],"translation":{"provider":"WPGlobus","version":"3.0.0","language":"fr","enabled_languages":["en","es","de","fr","ru","sv"],"languages":{"en":{"title":true,"content":true,"excerpt":false},"es":{"title":false,"content":false,"excerpt":false},"de":{"title":false,"content":false,"excerpt":false},"fr":{"title":false,"content":false,"excerpt":false},"ru":{"title":false,"content":false,"excerpt":false},"sv":{"title":false,"content":false,"excerpt":false}}},"_links":{"self":[{"href":"https:\/\/temporary.nolato.com\/fr\/wp-json\/wp\/v2\/mfn_news\/697","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/temporary.nolato.com\/fr\/wp-json\/wp\/v2\/mfn_news"}],"about":[{"href":"https:\/\/temporary.nolato.com\/fr\/wp-json\/wp\/v2\/types\/mfn_news"}],"wp:attachment":[{"href":"https:\/\/temporary.nolato.com\/fr\/wp-json\/wp\/v2\/media?parent=697"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}